Evolve Medical Education LLC

Ushering in a New Treatment Paradigm for Glaucoma: Updates on Novel Therapeutics and Disease-Modifying Treatments

Overview / Abstract:	CONTENT SOURCE This continuing medical education (CME)/continuing education (CE) activity captures content from a live event. ACTIVITY DESCRIPTION Medical/topical therapy is the first-line choice for most physicians treating patients with primary open-angle glaucoma (POAG), yet some patients will have visual field loss despite adequate IOP control. This supplement focuses on the investigative agents that will help deliver treatment in a more consistent and patient-friendly manner.
Expiration	Feb 13, 2023
Discipline(s)	Optometry / Ophthalmology CE
Format	Journal
Credits / Hours	1
Accreditation	ACCME, COPE/ARBO
Presenters / Authors / Faculty	Nathan M. Radcliffe, MD; Earl Randy Craven, MD; Preeya K. Gupta, MD; and Robert N. Weinreb, MD
Sponsors / Supporters / Grant Providers	Supported by an unrestricted educational grant from Allergan.
Keywords / Search Terms	Evolve Medical Education LLC Ophthalmology, Optometry, glaucoma, corneal disease, dry eye disease, IOP control, topical therapy Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map